Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Noul’s miLab™ platform provides rapid (<15 min), automated blood and tissue diagnostic results using AI-powered digital microscopy. It has demonstrated laboratory-grade accuracy for malaria detection and cancer cell analysis. The company’s solutions are deployed globally to improve access to timely diagnoses in resource-limited settings. Clinical performance metrics such as sensitivity/specificity are highlighted but not numerically specified in public sources.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Noul.